Prolyl-hydroxylase inhibitor-induced regeneration of alveolar bone and soft tissue in a mouse model of periodontitis through metabolic reprogramming
Bone injuries and fractures reliably heal through a process of regeneration with restoration to original structure and function when the gap between adjacent sides of a fracture site is small. However, when there is significant volumetric loss of bone, bone regeneration usually does not occur. In th...
Saved in:
Main Authors: | Elan Zebrowitz (Author), Azamat Aslanukov (Author), Tetsuhiro Kajikawa (Author), Kamila Bedelbaeva (Author), Sam Bollinger (Author), Yong Zhang (Author), David Sarfatti (Author), Jing Cheng (Author), Phillip B. Messersmith (Author), George Hajishengallis (Author), Ellen Heber-Katz (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice
by: Shunji Nishide, et al.
Published: (2020) -
Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
by: Jie Lun, et al.
Published: (2023) -
Human prolyl hydroxylase expression in uterine leiomyoma during the menstrual cycle
by: Iwahashi Masaaki, et al.
Published: (2012) -
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
by: Andrey A. Poloznikov, et al.
Published: (2021) -
Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state
by: Amit A. Joharapurkar, et al.
Published: (2022)